The interplay between thyroid and liver: implications for clinical practice - PubMed (original) (raw)
Review
. 2020 Jul;43(7):885-899.
doi: 10.1007/s40618-020-01208-6. Epub 2020 Mar 12.
S Ippolito 2, D Gallo 2, E Masiello 2, P Premoli 2, C Cusini 2, S Rosetti 2, J Sabatino 2, S Segato 3, F Trimarchi 4, L Bartalena 5, M L Tanda 2
Affiliations
- PMID: 32166702
- DOI: 10.1007/s40618-020-01208-6
Review
The interplay between thyroid and liver: implications for clinical practice
E Piantanida et al. J Endocrinol Invest. 2020 Jul.
Abstract
A complex relationship exists between thyroid and liver in health and disease. Liver plays an essential physiological role in thyroid hormone activation and inactivation, transport, and metabolism. Conversely, thyroid hormones affect activities of hepatocytes and hepatic metabolism. Serum liver enzyme abnormalities observed in hypothyroidism may be related to impaired lipid metabolism, hepatic steatosis or hypothyroidism-induced myopathy. Severe hypothyroidism may have biochemical and clinical features, such as hyperammonemia and ascites, mimicking those of liver failure. Liver function tests are frequently abnormal also in hyperthyroidism, due to oxidative stress, cholestasis, or enhanced osteoblastic activity. Antithyroid drug-associated hepatotoxicity is a rare event, likely related mainly to an idiosyncratic mechanism, ranging from a mild hepatocellular damage to liver failure. Propylthiouracil-induced liver damage is usually more severe than that caused by methimazole. On the other hand, thyroid abnormalities can be found in liver diseases, such as chronic hepatitis C, liver cirrhosis, hepatocellular carcinoma, and cholangiocarcinoma. In particular, autoimmune thyroid diseases are frequently found in patients with hepatitis C virus infection. These patients, especially if thyroid autoimmunity preexists, are at risk of hypothyroidism or, less frequently, thyrotoxicosis, during and after treatment with interpheron-alpha alone or in combination with ribavirin, commonly used before the introduction of new antiviral drugs. The present review summarizes both liver abnormalities related to thyroid disorders and their treatment, and thyroid abnormalities related to liver diseases and their treatment.
Keywords: Antithyroid drugs; Chronic hepatitis C; Hyperthyroidism; Hypothyroidism; Thyroid autoimmunity.
Similar articles
- Clinical associations between thyroid and liver diseases.
Huang MJ, Liaw YF. Huang MJ, et al. J Gastroenterol Hepatol. 1995 May-Jun;10(3):344-50. doi: 10.1111/j.1440-1746.1995.tb01106.x. J Gastroenterol Hepatol. 1995. PMID: 7548816 Review. - Factors affecting drug-induced liver injury: antithyroid drugs as instances.
Heidari R, Niknahad H, Jamshidzadeh A, Abdoli N. Heidari R, et al. Clin Mol Hepatol. 2014 Sep;20(3):237-48. doi: 10.3350/cmh.2014.20.3.237. Epub 2014 Sep 25. Clin Mol Hepatol. 2014. PMID: 25320726 Free PMC article. Review. - [Methimazole and propylthiouracil induced acute toxic hepatitis].
Casallo Blanco S, Valero MA, Marcos Sánchez F, de Matías Salces L, Blanco González JJ, Martín Barranco MJ. Casallo Blanco S, et al. Gastroenterol Hepatol. 2007 May;30(5):268-70. doi: 10.1157/13101979. Gastroenterol Hepatol. 2007. PMID: 17493435 Spanish. - [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
Parolin MB, Lopes RW, Telles JE, Ioshii SO, Hajar N. Parolin MB, et al. Arq Gastroenterol. 2000 Apr-Jun;37(2):129-32. doi: 10.1590/s0004-28032000000200011. Arq Gastroenterol. 2000. PMID: 11144016 Portuguese. - Propylthiouracil-induced hepatic damage.
Ozenírler S, Tuncer C, Boztepe U, Akyol G, Alkim H, Cakir N, Kandílć U. Ozenírler S, et al. Ann Pharmacother. 1996 Sep;30(9):960-3. doi: 10.1177/106002809603000909. Ann Pharmacother. 1996. PMID: 8876856
Cited by
- Liver Dysfunction in Hyperthyroidism.
Khongsaengbhak T, Atthakitmongkol T, Tanwandee T. Khongsaengbhak T, et al. Hepat Med. 2024 Nov 8;16:81-89. doi: 10.2147/HMER.S487794. eCollection 2024. Hepat Med. 2024. PMID: 39534784 Free PMC article. - Association of hepatitis B virus and thyroid hormones during pregnancy.
Wang J, Yang X, Liang X, Zhang Y. Wang J, et al. Medicine (Baltimore). 2024 Oct 4;103(40):e39925. doi: 10.1097/MD.0000000000039925. Medicine (Baltimore). 2024. PMID: 39465763 Free PMC article. - Propylthiouracil Induced Rat Model Reflects Heterogeneity Observed in Clinically Non-Obese Subjects with Nonalcoholic Fatty Liver Disease.
Jin Y, Liu Q, Wang Y, Wang B, An J, Chen Q, Wang T, Shang J. Jin Y, et al. Int J Mol Sci. 2024 Oct 7;25(19):10764. doi: 10.3390/ijms251910764. Int J Mol Sci. 2024. PMID: 39409093 Free PMC article. - Causal association between hyperthyroidism and risk of gastroesophageal reflux or esophageal cancer: a bidirectional Mendelian randomization investigation.
Zhu X, Li M, Gan H, Guo Y. Zhu X, et al. Front Endocrinol (Lausanne). 2024 Sep 17;15:1411629. doi: 10.3389/fendo.2024.1411629. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39355614 Free PMC article. - Evaluation of MELD Scores and Thyroid Hormones as Prognostic Factors of Liver Cirrhosis.
Belu AM, Nicoara AD, Belu DM, Circo E. Belu AM, et al. Medicina (Kaunas). 2024 Sep 9;60(9):1474. doi: 10.3390/medicina60091474. Medicina (Kaunas). 2024. PMID: 39336515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources